Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
about
Vitamin D and cardiovascular disease prevention.Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population.Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with LupusInfluence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trialsThe use of vitamin D analogues in chronic kidney diseases: possible mechanisms beyond bone and mineral metabolism.Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterolTheoretical basis of a beneficial role for vitamin D in viral hepatitis.Structure, function and amyloidogenic propensity of apolipoprotein A-I.Obesity-related changes in high-density lipoprotein metabolism.Vitamin D Supplementation and High-Density Lipoprotein Cholesterol: A Study in Healthy School Children.Vitamin D and cardiometabolic health: a review of the evidence.The effect of nutritional supplements on serum high-density lipoprotein cholesterol and apolipoprotein A-I.Dyslipidemia in patients with chronic kidney disease.Vitamin D Deficiency: A Potential Modifiable Risk Factor for Cardiovascular Disease in Children with Severe Obesity.Pediatric endocrinology: vitamin D and cardiovascular disease risk in children.Regular consumption of both vitamin D- and calcium- and vitamin D-fortified yogurt drink is equally accompanied by lowered blood lipoprotein (a) and elevated apoprotein A1 in subjects with type 2 diabetes: a randomized clinical trial.Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial.1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial.
P2860
Q30251419-8A4E287E-1D00-44FF-BEB4-EAAA5ACE7C1BQ33577888-7CFB312C-E2F2-4C59-8A6D-4AB6E8F34EC3Q33644604-007F391D-D735-4B9A-ACD7-337CA5302F3AQ34203476-B6A09D8A-8B43-48A7-B52B-C4125BEDFEAAQ35573698-6A87FEE3-CCDD-4C9C-808C-AF59C74B843EQ35907312-D90924CB-0A2B-4E52-8D7C-96894CDA6B77Q36316676-1D6AC187-0F3C-4913-898D-719483C9F86DQ36654590-18E0BC42-3421-4B08-845C-F2F18C04CF6EQ37128676-2482B8E4-648A-4E5D-880F-0D37EB1FFC0EQ37302490-E6E518ED-12E9-4545-8E4D-8C3CA87F8699Q37813833-41ED672E-F350-4697-951E-79D34D3BE5B1Q38194113-5636C1DE-7200-42F4-970B-E336C6E1FA7AQ39045120-AB40CF0F-F83E-439B-B149-FD4692EA0060Q41671313-6A6F63AF-699D-4047-B077-47EE84C0DE34Q43221572-D307414A-B7C4-4E12-ACF7-2DCC7B8D1694Q47960211-D005D169-B351-4015-88C9-7690211014C7Q48069746-E6C74C82-65C8-4EF7-9C21-E3D3ED5518F0Q51584487-8900DE25-F2B9-4290-8DEC-917F096E6106Q53135887-6F44B7D8-063D-4C6A-AB01-0C972F03B838
P2860
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@ast
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@en
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@nl
type
label
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@ast
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@en
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@nl
prefLabel
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@ast
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@en
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@nl
P2093
P3181
P1476
Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3
@en
P2093
Andreas Steinmeyer
Arshag D Mooradian
Kent Wehmeier
Michael J Haas
Norman C W Wong
Ulrich Zugel
P3181
P356
10.1016/J.BBALIP.2005.09.004
P407
P577
2005-10-15T00:00:00Z